Foresite Capital Management II as of Sept. 30, 2018
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 10 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 33.4 | $90M | 1.5M | 61.55 | |
| Aimmune Therapeutics | 33.3 | $90M | 3.3M | 27.28 | |
| Alder Biopharmaceuticals | 9.8 | $26M | 1.6M | 16.65 | |
| Insmed (INSM) | 7.2 | $20M | 968k | 20.22 | |
| Epizyme | 5.6 | $15M | 1.4M | 10.60 | |
| Acceleron Pharma | 4.7 | $13M | 220k | 57.23 | |
| Adaptimmune Therapeutics (ADAP) | 2.5 | $6.8M | 500k | 13.56 | |
| Denali Therapeutics (DNLI) | 2.0 | $5.4M | 250k | 21.74 | |
| BioDelivery Sciences International | 1.0 | $2.7M | 949k | 2.80 | |
| Sangamo Biosciences (SGMO) | 0.5 | $1.4M | 81k | 16.94 |
